In terms of SEBI (Prohibition of Insider Trading) Regulation, 2015 the trading window for dealing in securities of Jagsonpal Pharmaceuticals Limited shall remain closed for Designated persons and their immediate relative(s) with effect from Wednesday, January 01, 2025 till the end of 48 hours after the declaration of Unaudited Financial Results for the quarter and nine months ended December 31, 2024.